The effect of TREM2 levels on AD biomarkers and clinical outcomes has garnered significant interest as detailed earlier but there are limited studies of the effects of TNFR2 on AD biomarkers and on clinical outcomes in different stages of AD. The gene discussed is TNFRSF1B; the disease is Alzheimer disease.